Tel Aviv University Opens Israel’s First Autoimmune Disease Research Center

Tel Aviv University has launched the Colton Center for Autoimmunity, Israel’s first multidisciplinary research center dedicated to autoimmune diseases — a category spanning more than 100 conditions, including lupus, multiple sclerosis, psoriasis, and Crohn’s disease. The center was made possible by a $10 million gift from TAU Governors Judith and Stewart Colton, extending a philanthropic effort that already supports three sister centers at Yale University, the University of Pennsylvania, and NYU.

What sets the Colton Center apart is its foundational reliance on big data analytics. Rather than beginning with traditional lab work, researchers will first analyze large-scale clinical data and biological samples from patients across Israel’s hospitals, HMOs, and health services. These computational insights will then guide experimental and theoretical research across disciplines — from biomedical engineering and computer science to mathematics, statistics, and psychology.

The center is chaired by Prof. Uri Nevo of TAU’s Department of Biomedical Engineering, himself a Colton Fellow alumnus. Its near-term goals include identifying early biomarkers, developing predictive algorithms for disease onset and flare-ups, and establishing practical prevention recommendations. Longer term, the center aims to uncover the biological mechanisms driving autoimmune conditions and inform new treatment strategies.

Despite being recognized by science for over a century, autoimmune diseases remain poorly understood, with few targeted therapies available and many cases becoming chronic. The Colton Center joins a four-university consortium with the shared mission of changing that — bringing Israeli clinical expertise and research talent to bear on one of medicine’s most persistent challenges.